1.Executive Summary
From risk forecast to operational reality
The "Mood" Index: December 2025
The structural fracture becomes reality
December 2025 will be recorded in the annals of German industrial history as the moment the "structural fracture" transitioned from a risk forecast to an operational reality. For nearly three years, the narrative surrounding the German chemical industry has oscillated between cyclical pessimism and deep-seated structural anxiety.
The VCI Annual Balance on December 10, 2025, effectively retires the "cyclical" argument. The crisis is structural, deep, and accelerating, marked by a decoupling of global corporate fortunes from the domestic industrial base. Chemical production is down 2.5%, turnover shrinking, and capacity utilization languishing at a historic low of 70%.
The strategic developments reinforce this diagnosis through a dichotomy of survival strategies. Wacker Chemie and Evonik initiated aggressive "right-sizing" programs, announcing thousands of job cuts. Meanwhile, BASF secured a new site agreement for Ludwigshafen, trading job security for a commitment to transformation—buying time to pivot towards a "Green Verbund".
Key Indicators at a Glance
Chemical Production
-2.5%
FY 2025 (VCI)
Capacity Utilization
70%
Historic low
Site Closures Planned
10%
of VCI members
Covestro Takeover
81.77%
ADNOC acceptance
The Global Decoupling
This domestic contraction stands in sharp contrast to the global projection of +2.9% growth in chemical production, driven by China (+5.0%), India (+3.0%), and South Korea (+3.0%). Germany is not just growing slower; it is shrinking while the rest of the world expands.
Top 3 Headline Events
VCI Annual Balance: The "SOS" Signal
The VCI declared the industry is "sending out an SOS." Production down 2.5%, capacity utilization at 70%, and 50% of companies report order shortages. The forecast for 2026: zero growth overall, with chemical sector continuing to decline 1%.
Strategic Implications
- •20% of companies planning to relocate or shut down capacity
- •Over 40% expect further declines in domestic sales
- •Production volume now nearly 20% below 2018 levels
Covestro-ADNOC: The Sovereignty Transfer
The ADNOC takeover secured 81.77% acceptance at €62 per share. This transfers a premier German material science company to Gulf sovereign ownership—the ultimate signal that German chemical assets are undervalued relative to technology but uninvestable due to location costs.
Strategic Implications
- •Largest takeover of German chemical company by sovereign wealth fund
- •Removes major industrial pillar from DAX active equity story
- •Energy risk transferred to owner with unlimited energy access
DOMO Insolvency: Mittelstand Firewall Breached
DOMO Chemicals filed for insolvency on December 30 for its German subsidiaries in Leuna and Premnitz. Explicitly linked to "years of weak demand" and surge in Chinese polyamide imports, this signals the mid-sized chemical supplier base is fracturing.
Strategic Implications
- •Supply security concerns for German automotive manufacturers
- •Chinese overcapacity (93% surplus in epichlorohydrin) flooding markets
- •Mittelstand supply chain for automotive industry at risk of permanent fracture
Strategic Conclusions
Capital Allocation
- →Defensive regarding Germany (Standort D)
- →Offensive regarding US and China expansion
- →Transformation overshadowed by rationalization
Political Reality
- →Grid fee subsidies 2026: band-aid, not solution
- →Gap between Green Deal and industrial reality never wider
- →Structural guarantees for CapEx decisions absent
2.Macroeconomic & Regulatory Landscape
VCI Annual Balance and Policy Developments
The VCI's 2025 Annual Balance on December 10 confirmed the "structural fracture" thesis. Chemical production down 2.5%, capacity utilization at 70%, and 10% of companies planning site closures. The energy cost gap with international peers has become permanent, not cyclical.
The Energy Cost Reality
Electricity Costs Germany
Nearly doubled
Often <5 ct in US
Band-aid solution
VCI December 2025 Survey
of companies
of members
Moving abroad
Domestic sales drop
Hydrogen Reality: RWE & TotalEnergies
On December 24, RWE began commissioning the first 100 MW of electrolyzer capacity in Lingen—Europe's largest green hydrogen facility.
- • Part of "GET H2 Nukleus" project, aiming for 300 MW by 2027
- • Green hydrogen for TotalEnergies Leuna refinery
- • 600-km pipeline to German hydrogen core network
Significant proof of concept, but GW scale needed for industrial transformation.
€6B CCS Pivot: Carbon Contracts for Difference
Germany launched a €6 billion industrial decarbonization program explicitly including Carbon Capture and Storage (CCS)—a major policy reversal.
- • Carbon Contracts for Difference (CCfDs) mechanism
- • State pays gap between CO2 avoidance cost and ETS price
- • Applications due Dec 1, auctions expected mid-2026
A lifeline for "hard-to-abate" sectors—but too late for companies already facing insolvency.
VCI Annual Balance 2025: The Numbers
| Indicator | Chemicals Only | Pharma Sector | Strategic Implication |
|---|---|---|---|
| Production | -2.5% | +3.0% | 20% below 2018 levels; structural collapse |
| Total Turnover | -3.0% | +4.5% | Pharma masks severity of industrial decline |
| Foreign Revenue | -3.5% | +3.5% | Export competitiveness eroding |
| Capacity Util. | 70% | — | Historic low; below 80-85% breakeven threshold |
2026 Outlook: VCI forecasts zero growth for combined industry, with chemical sector declining another 1%. "L-shaped" stagnation confirmed.
Inorganic Basics
-4.5%
Inorganic Basic Chemicals FY25
Chlorine, ammonia, sulfuric acid—the building blocks
Polymers Down
-3.5%
Standard Polymers FY25
Impacting automotive and packaging
2026 Outlook: Three Storm Fronts
Trump Tariff Shock
NegativeWith the implied re-election of Donald Trump leading to protectionist trade policies, the German export model faces a severe stress test. Companies like Lanxess and Evonik could face margin compression.
Impact: Accelerated 'local-for-local' production strategy; further CAPEX diversion from Germany to US.
Insolvency Wave Expected
NegativeGas and electricity prices have stabilized at a 'new normal' structurally too high for basic ammonia and commoditized polyamides. A second wave of Mittelstand insolvencies is expected in Q1 2026.
Impact: Mittelstand supply chain for automotive at risk of permanent fracture.
Election Year Paralysis
MixedGerman Federal Elections cast a shadow over 2025/2026. Implementation of the Kraftwerksstrategie and Carbon Contracts for Difference may face bureaucratic delays.
Impact: Policy vacuum could extend the investment strike by major chemical companies.
Winner/Loser Profile
PositiveWinners: Pharma, Biotech, US-exposed distributors (Brenntag), Consumer specialties (Henkel). Losers: Basic Inorganics, Standard Polymers, European-focused construction chemicals.
Impact: The industry is shrinking to become leaner, greener, and more specialized\u2014but undeniably smaller.
"The industry is sending out an SOS. December 2025 will be recorded as the moment the 'structural fracture' transitioned from risk forecast to operational reality."
3.Corporate Movers & Shakers
The Structural Fracture in Action
December 2025 crystallized the strategic divergence across the German chemical sector. While BASF secured a defensive accord for Ludwigshafen, Wacker and Evonikannounced aggressive right-sizing programs. The ADNOC-Covestro takeover reached completion, and DOMO Chemicals' insolvency signals the first Mittelstand casualty of the structural crisis.
BASF SE: The Ludwigshafen Accord
BASF SE
BAS.DENew Site Agreement Secures Job Security Until 2028
- •December 15: New site agreement for Ludwigshafen Stammwerk concluded
- •No compulsory redundancies until December 31, 2028
- •Investment commitment: €1.5–2.0 billion annually in modernization
- •Focus on infrastructure and green energy integration, not capacity expansion
- •Deutsche Bank downgraded to 'Hold' on challenging outlook extending into 2026
Outlook: Defensive crouch. Job security bought at the price of frozen headcount. Transformation over expansion.
Agricultural Innovation
R&D Push
Showcased new cotton traits for improved yield and sustainability in December.
Analyst Skepticism
Deutsche Bank forecasts just 3% EBITDA growth for 2026, significantly below consensus.
Covestro AG: The ADNOC Finale
By December 19, 2025, ADNOC secured 81.77% of Covestro shares—a watershed moment. One of Germany's premier material science companies is now effectively an asset of a Gulf sovereign entity.
Strategic Implication
Energy risk transferred to owner with unlimited energy access
Market Signal
German chemical assets undervalued due to location costs
DAX Impact
Major industrial pillar removed from German equity market
The Restructuring Wave
Wacker Chemie AG
WCH.DE€300M Savings Target, 1,500 Job Cuts
- •December 2: 'PACE' efficiency program announced
- •€300 million annual savings targeted by end-2027
- •1,500 jobs cut globally, heavily weighted towards Germany
- •CEO cited German energy costs and bureaucracy as 'central brake'
- •Strategic retreat to semiconductor-grade polysilicon
Outlook: Market read job cuts as distress signal. Moving from growth to defensive posture.
Evonik Industries AG
EVK.DEAdministrative Decimation: 1,500 in Germany
- •2,000 jobs to be eliminated by 2026
- •1,500 of those positions in Germany specifically
- •Targeting 'disproportionate number of management positions'
- •Elias Lacerda appointed President for Americas—geographic pivot signal
- •German HQ function deemed too expensive vs. global value added
Outlook: Hollowing out of corporate center. Americas designated growth engine; Germany is cost center to manage.
The Insolvency Wave: DOMO Chemicals
DOMO Chemicals filed for insolvency for its German subsidiaries in Leuna and Premnitz—the first major Mittelstand casualty of the structural crisis. Explicitly linked to "years of weak demand" and surge in Chinese polyamide imports.
CHINA SHOCK 2.0
93% surplus in Chinese epichlorohydrin production flooding European markets
SUPPLY CHAIN RISK
German auto manufacturers face supply security concerns for engineering plastics
Relative Resilience
Brenntag SE
BNR.DEAggressive Inorganic Growth
- •December 16: Acquired Airedale Group in UK (blending/formulation)
- •Acquired Chem Tech Services in US Permian Basin
- •Two German Sustainability Awards in December
- •Betting on US energy boom—hedge against European disadvantage
Outlook: Buying growth the organic market cannot provide. Value-added distribution moat.
Henkel AG
HEN3.DEInnovation Amidst Crisis
- •New 'gold' color thin organic coating (TOC) for metal surfaces
- •Consumer staples providing cash flow stability
- •Performance selling insulates from raw material volatility
- •One of few names with stable/Buy outlook
Outlook: Stable. Strong cash flow. Consumer exposure provides buffer against industrial headwinds.
Merck KGaA
MRK.DEThe Asian Pivot
- •December 1: Inaugurated new Semiconductor Solutions site in Taiwan
- •Pimicotinib approved in China for tenosynovial giant cell tumors
- •Launched ChemiSphere app for digital lab access
- •High-tech chemical investment center of gravity shifting to East Asia
Outlook: Different cycle\u2014pharma and semiconductors. Expanding while others cut.
Strategic Divergence Summary
Expanding
- Merck: Taiwan semiconductor site + AI
- Henkel: Consumer resilience + innovation
- Brenntag: Aggressive M&A in US/UK
Restructuring
- BASF: Ludwigshafen accord, frozen growth
- Evonik: 2,000 jobs, admin decimation
- Wacker: PACE program, 1,500 cuts
Distressed / Exiting
- Covestro: Sold to ADNOC (81.77%)
- DOMO: Insolvency filed Dec 30
- INEOS: Rheinberg closures, 450 jobs
4.Innovation & Transformation
Green Chemistry Between Ambition and Reality
The current crisis is forcing a bifurcation in innovation: projects with immediate efficiency gains or those subsidized by the state are proceeding, while speculative "green" projects without a clear business case are stalling.
The Hydrogen Reality Check
Germany's Hydrogen Ambitions Face Harsh Reality
Reports surfaced in late November indicating that the German hydrogen market is developing significantly slower than political targets suggest. The "core network" infrastructure rollout is facing delays, and the cost gap between green hydrogen and fossil gas remains unbridgeable without massive, continuous subsidies.
Green Hydrogen (Electrolysis)
Companies hesitant to sign 10-year offtake agreements for expensive green hydrogen when their own production futures in Germany are uncertain.
- •EWE constructing 320 MW hydrogen plant in Emden—proceeding, but broader adoption lagging
- •Cost gap vs. natural gas remains prohibitive without continuous subsidies
- •Infrastructure rollout (core network) facing significant delays
Verdict: Market development far behind political targets. Commercial viability elusive.
Turquoise Hydrogen (Methane Pyrolysis)
BASF's collaboration with ExxonMobil on methane pyrolysis advancing as pragmatic alternative.
- •Uses existing natural gas infrastructure—lower transition costs
- •Produces hydrogen + solid carbon, avoiding CO2 emissions
- •Does not require massive renewable electricity loads of electrolysis
- •'Technology-open' approach gaining favor as pragmatic path
Verdict: Promising alternative for industrial hydrogen. Gaining momentum.
Biomass and the Circular Economy
Biomass Initiative
A critical report emerged highlighting the 'failure' of Germany's biomass initiative to boost the chemical industry.
- •Despite high-profile investments (UPM biorefinery in Leuna), scaling faltering
- •Logistic complexities and high biomass costs vs. petrochemicals
- •Wood-based chemicals proving economically unviable at scale
- •Bio-economy remains niche rather than steam cracker replacement
Verdict: Biomass will remain marginal in near term. Not the structural solution hoped for.
Mass Balance Approach
BASF secured ISCC EU certification for biomass-balanced methanol portfolio in November.
- •Feed bio-waste into existing plants, mathematically attribute green content
- •'Drop-in' solution: works with existing infrastructure
- •Only commercially viable path for green chemicals in current environment
- •Allows gradual transition without massive capital outlays
Verdict: Proving to be the only economically viable path forward. Expect wider adoption.
Technology & Innovation Highlights
Nobel Prize Validation: MOFs
The global recognition of Metal-Organic Frameworks (MOFs) with the Nobel Prize in Chemistry (December 10) highlighted German industrial leadership.
BASF has been a pioneer in scaling MOF production for CO2 capture and industrial applications. This proves that R&D engines in Germany are still capable of world-class innovation, even if production economics are challenged.
Automotive Tech: trinamiX
trinamiX (a BASF subsidiary) announced it will unveil new biometric driver-monitoring technology at CES 2026.
This underscores the strategic shift toward high-value functional components(sensors, optics) where German engineering can still command a premium over commodity chemicals.
Carbon Capture & Storage (CCS)
Bundestag Approval (Nov 6): The Carbon Storage Act finally creates a legal framework for CCS/CCU in Germany. For the chemical industry with unavoidable process emissions, this is crucial enabling technology for decarbonization.
Reality Check: The infrastructure to transport captured CO2 to storage sites (likely offshore in the North Sea) is still years away. The legislative progress is necessary but not sufficient for near-term impact.
The Innovation Bifurcation
Proceeding
- →Mass balance approach (BASF certified)
- →Methane pyrolysis / turquoise hydrogen
- →High-value tech components (sensors, optics)
- →MOFs and advanced materials
Stalling
- →Large-scale green hydrogen without subsidy
- →Biomass-based chemical scaling
- →Speculative "green" projects without clear ROI
- →Projects requiring new German CapEx commitment
5.Financial Radar
Stock Performance, Valuations, and the Flight from Cyclicals
The capital markets in November 2025 delivered a clear verdict: investors are fleeing cyclical, energy-intensive German assets. With the exception of special situations (Covestro) or defensive plays (Henkel, BASF dividend yield), the sector significantly underperformed the DAX.
Sector Overview
Sector YTD
-8.3%
STOXX Chemicals
Average P/E
14.2x
vs. 18x historical
Dividend Yield
4.1%
Big 5 average
EV/EBITDA
7.8x
Cyclical trough
November 2025 Stock Performance
Outperformer. Over 5% dividend yield + potential value unlocking from Agricultural Solutions IPO. 'Too cheap to ignore' thesis.
Defensive anchor. Share buyback program and steady consumer demand provided a floor. Insulated from industrial rout.
Volatile. Historic lows (P/E about 4x). Slight uptick reflects short covering and hope that accelerated cuts improve cash flow. Deep skepticism on debt and litigation.
Pegged to takeover price (around 62 Euro). Now an arbitrage play awaiting ADNOC deal closure. Decoupled from fundamental sentiment.
Negative. Job cut announcement read as distress signal rather than efficiency. Solar pricing exposure a major drag.
Deep red. Sharp sell-off following Q3 earnings miss. Investors capitulating on hope for construction recovery in 2025.
Crisis level. Profit warning and 'no light at end of tunnel' commentary decimated the stock. High leverage concerns. Most shorted in sector.
Analyst Sentiment: The Sell Side Capitulation
November 2025 marked a turning point in analyst sentiment, moving from wait and see to sell.
Prolonged Downturn Warning
- -Major sector report warning of existential crisis for parts of European chemical industry
- -Slashed price targets across the board
- -Notable: Evonik cut from 16 Euro to 13 Euro
Longest Downcycle on Record
- -Downgraded European chemical distributors
- -Maintained cautious stance on producers
- -Structural headwinds prevent V-shaped recovery
Consensus View: The Value Trap Thesis
The banking sector has abandoned the narrative of a cyclical recovery in H2 2025. The consensus is now pricing in an L-shaped stagnation.
Many German chemical stocks are viewed as value traps - cheap on multiples but structurally impaired on cash flow generation due to uncompetitive energy costs.
Investment Thesis Summary
Potential Upside
- -BASF: Dividend yield + IPO catalyst
- -Henkel: Consumer stability + buybacks
- -Merck: Different cycle (pharma/semi)
Special Situations
- -Covestro: Arb play, pegged to 62 Euro
- -Bayer: Deep value if litigation clears
Avoid / Short
- -Lanxess: Leverage + no visibility
- -Wacker: Solar exposure, China dumping
- -Evonik: Construction cycle dependent
The VCI prediction of a 2025 without a happy end appears to be the most accurate forecast for the coming winter. Unless the German government upgrades the Grid Fee Subsidy to a comprehensive Industrial Power Price, the exodus of capital expenditure will accelerate.